Navigation Links
FDA Approves Test That Spots Aggressive Breast Cancer
Date:6/14/2011

now if her treatment will be over within a few months, or might go on for a full year," Bernick said.

Dr. Freya Schnabel, director of Breast Surgery at NYU Langone Medical Center, said: HER2 testing is an "important part of the assessment of breast cancer tissue, because it tells us important information about the biology of the tumor and also helps identify the subset of patients who would benefit from treatment with Herceptin. At this point, testing for HER2/neu frequently involves two levels of testing and there is sometimes lack of agreement between test results, making a patient's status unclear."

The new test is made by Tucson, Ariz.-based Ventana Medical Systems.

More information

The American Cancer Society has more about breast cancer.

-- Robert Preidt

SOURCES: Stephanie Bernik, M.D., chief of surgical oncology, Lenox Hill Hospital, New York City; Freya Schnabel, M.D., director of Breast Surgery, NYU Langone Medical Center, New York City; U.S. Food and Drug Administration, news release, June 14, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Kaiser Permanente Approves $170 Million in Community Benefit Grants in 2009
2. The American Association of Anatomists approves guidelines for body donation programs
3. Golden Meditech Shareholders Approves of Name Change
4. New Jersey Approves Initiative to Expand the Number of Wound Care Certified Professionals
5. Congress Approves Bill Curbing Internet Tobacco Sales in Victory for Kids and Taxpayers
6. House of Representatives Approves Health-Care Reform Bill
7. New York State Office of Mental Health Approves New High Performance Polycarbonate Sheet for Use in All Facilities
8. FDA Approves Stemedica IND for Ischemic Stroke Clinical Trial
9. FDA approves first human neural stem cell clinical trial to treat brain tumors
10. Early detection of cancer: The FDA approves procedure discovered by EPFL researchers
11. FDA approves Merz Pharmaceuticals Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves Test That Spots Aggressive Breast Cancer
(Date:6/17/2013)... 2013 Essential tremor (ET) is the ... 10 million people in the United States, and millions ... understanding what causes ET, there are no medications specifically ... Tulips for Tremor© is the International Essential Tremor Foundation’s ... and a cure for this life-altering neurological condition. , ...
(Date:6/17/2013)... initiative helped to boost organ donor registration rates, according ... Journal of Transplantation . The findings suggest that social ... variety of problems related to public health in which ... rates in the United States have remained static while ... year. To provide organs to the more than 100,000 ...
(Date:6/17/2013)... 17, 2013 "Do you think you and ... emailing or using your phone even with a hands free ... is just as dangerous as not using a hands free ... you using Facebook, texting, emailing etc." , It ... their reflexes that distract the brain, according to a study ...
(Date:6/17/2013)... 2013 The personal injury trial ... pleased to announce that firm Partners Stephen J. ... ( http://www.blockotoole.com/Attorneys/David-L-Scher.shtml ) will be appearing on hit ... Sunday, June 23, 2013 at 7a.m. Mr. ... Kevin Burke's "Get Active" show, which highlights professionals ...
(Date:6/17/2013)... Angeles (PRWEB) June 17, 2013 According to ... Sunscreen Questions Answered,” as more and more information surfaces about ... sunscreen should become a vital part of one’s skin ... aging and cancer (Go to goo.gl/qTKZQ). , “I agree ... sunscreen,” says Dr. Simon Ourian, Medical Director of Epione Beverly ...
Breaking Medicine News(10 mins):Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:Social media initiative may help increase organ donations 2Health News:Dr. Bonnie Weil Warns Hands Free is Not a Life Saver, It Can Be Just as Much of a Distraction 2Health News:Injury Attorneys Block O'Toole & Murphy, LLP to Appear on Z100 Radio Show This Sunday to Discuss Their Support of St. Jude Children's Research Hospital 2Health News:Skin Care – Answers to Your Sunscreen Questions 2
... BOSTON--A duo of drugs, each targeting a prime survival ... potentially more effective than either drug alone for advanced, ... led by Dana-Farber Cancer Institute investigators. The findings ... at the annual meeting of the American Society of ...
... , FRIDAY, JUNE 3 (HealthDay News) -- People ... a heart attack or serious cardiac event, a new ... is that people with mental illness are 14 percent ... condition, researchers found. Those treatments included coronary artery ...
... June 3 (HealthDay News) -- A new strain of ... has been detected in cows, milk in the United ... the department of veterinary medicine at the University of ... new variant, which is genetically different than existing MRSA ...
... tsunami, tornado or flood strike, among the most vulnerable ... Journal of Emergency Management , researchers in New Zealand ... the age-related needs of adults with regards to the ... Tuohy and Christine Stephens of Massey University in Palmerston ...
... School of Medicine (BUSM) researchers have found that Gabapentin, ... neuropathic pain, seizures and biopolar disease in older and ... anorgasmia, or failure to experience orgasm, than previously reported. ... the American Journal of Geriatric Pharmacotherapy . ...
... nationwide hospital databases, University of Cincinnati (UC) emergency medicine ... treatment with the standard therapy for acute ischemic stroke ... Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the ... the journal Stroke . The study estimates between ...
Cached Medicine News:Health News:Combination antibody therapy shows promise in metastatic melanoma 2Health News:Mental Illness Linked to Greater Risk of Death After Heart Attack 2Health News:Helping the aged during natural disasters 2Health News:Use of clot-busting drug for US stroke patients doubled from 2005 to 2009 2
(Date:6/17/2013)... Actavis, Inc. (NYSE: ACT ) today ... decision of the U.S. Court of Appeals for the Eleventh ... motion to dismiss the Federal Trade Commission,s lawsuit, FTC ... result of a decision by a 5 to 3 vote.  ... adopted the traditional "rule of reason" as the standard.  ...
(Date:6/17/2013)... TEL AVIV, Israel , June 17, 2013 /PRNewswire/ ... 2013, the Board of Governors of the Israel-U.S. Binational ... $10.95 million in funding for fourteen new projects between ... from BIRD , the projects will access private ... to approximately $33 million. The semi-annual meeting was held ...
(Date:6/17/2013)... NEW ORLEANS , June 17, 2013 /PRNewswire/ ... for new technologies that will help improve medication ... process across its health system. ... a combination of hardware and software that helps ... to dispense and administer medications because of simpler, ...
Breaking Medicine Technology:U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 2U.S. Supreme Court Reverses U.S. Court of Appeals Decision in FTC v. Actavis 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 2BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 4Ochsner Health System Improves Safety Through Advanced Medication Management Technology 2Ochsner Health System Improves Safety Through Advanced Medication Management Technology 3Ochsner Health System Improves Safety Through Advanced Medication Management Technology 4Ochsner Health System Improves Safety Through Advanced Medication Management Technology 5
... 23 Neurobiological Technologies, Inc. (Nasdaq: NTII ) ("NTI") ... extraordinary dividend of $0.18 per share of common stock, which ... record as of November 30, 2009. The December 9, 2009 ... pursuant to a plan of complete liquidation and dissolution and ...
... Calif., Nov. 23 Advanced Sterilization Products (ASP), ... today the acquisition by its French affiliate, Apsis ... of innovative disinfection processes and technologies to prevent ... disclosed. , Gloster Europe designs and markets ...
Cached Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2
... design and architectural philosophy of the Kenneth ... stylish, targeted to a discerning customer who ... cues directly from Kenneth Cole New York ... Contemporary crystal tones in multi-laminations craft the ...
... Girl Eyewear extends that easy, breezy, beautiful ... styles, featuring an array of stylish colors, ... ,The collection is designed to target the ... who demands affordability,and high-quality, fashionable frames. The ...
... is a memory metal segment under the Charmant ... better fitting frame that's comfortable yet durable. Small ... or break won't faze CFX because it automatically ... classic to modern to sporty and is coupled ...
... Collection is the world's most extensive ... 100% pure titanium and beta-titanium frames ... superior corrosion resistance. This coupled with ... a collection that is a step ...
Medicine Products: